Financial Ratios

SMS PHARMACEUTICALS LTD.

NSE : SMSPHARMABSE : 532815ISIN CODE : INE812G01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE178.05-0.6 (-0.34 %)
PREV CLOSE ( ) 178.65
OPEN PRICE ( ) 181.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12033
TODAY'S LOW / HIGH ( )177.85 182.65
52 WK LOW / HIGH ( )54.5 197.3
NSE178.25-1 (-0.56 %)
PREV CLOSE( ) 179.25
OPEN PRICE ( ) 181.25
BID PRICE (QTY) 178.25 (350)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 130683
TODAY'S LOW / HIGH( ) 178.00 182.95
52 WK LOW / HIGH ( )54.75 198
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.488.047.203.864.90
   CEPS(Rs)4.2811.849.836.477.17
   DPS(Rs)0.300.300.300.250.25
   Book NAV/Share(Rs)58.4958.3350.5943.4040.16
   Tax Rate(%)26.400.9033.0935.6033.52
Margin Ratios
   Core EBITDA Margin(%)9.9120.7219.9417.7517.95
   EBIT Margin(%)4.9815.8516.8413.9914.79
   Pre Tax Margin(%)1.0012.3915.0011.2612.41
   PAT Margin (%)0.7412.2810.047.258.25
   Cash Profit Margin (%)6.5518.0913.7012.1412.09
Performance Ratios
   ROA(%)0.457.808.235.337.39
   ROE(%)0.8314.7615.329.2412.93
   ROCE(%)3.6712.2617.0712.5715.96
   Asset Turnover(x)0.610.640.820.740.90
   Sales/Fixed Asset(x)0.970.981.321.291.53
   Working Capital/Sales(x)3.553.075.336.137.72
Efficiency Ratios
   Fixed Capital/Sales(x)1.041.020.760.780.65
   Receivable days65.0150.8046.4030.2718.23
   Inventory Days156.71128.1280.21107.4988.61
   Payable days101.1591.6859.0168.2954.22
Valuation Parameters
   PER(x)119.7911.6717.276.9012.71
   PCE(x)13.517.9312.654.128.68
   Price/Book(x)0.991.612.460.611.55
   Yield(%)0.520.320.240.940.40
   EV/Net Sales(x)1.411.942.240.891.41
   EV/Core EBITDA(x)12.318.4010.144.337.01
   EV/EBIT(x)26.6811.4712.355.848.83
   EV/CE(x)0.801.121.490.581.11
   M Cap / Sales0.941.531.870.551.13
Growth Ratio
   Net Sales Growth(%)0.42-7.6936.71-11.390.00
   Core EBITDA Growth(%)-50.28-3.7146.34-8.99-2.28
   EBIT Growth(%)-68.66-14.1662.21-15.09-2.05
   PAT Growth(%)-94.0011.6086.50-21.142.47
   EPS Growth(%)-94.0011.6086.50-21.142.47
Financial Stability Ratios
   Total Debt/Equity(x)0.510.530.590.410.42
   Current Ratio(x)1.611.851.541.481.42
   Quick Ratio(x)0.730.670.890.640.54
   Interest Cover(x)1.254.589.145.126.23
   Total Debt/Mcap(x)0.520.330.240.680.27

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.